RFID Pharmaceutical Solution: Pharmaceutical Industry Combats Drug Counterfeiting With Acsis Solution
NASDS Show Attendees To See Track & Trace Solution in Action
Acsis, Inc., the leader in connecting people, devices and supply chains, today announced its Serialized Track and Trace Solution is gaining popularity in the pharmaceutical market. Leading drug manufacturers have turned to Acsis to help curb an alarming increase in drug counterfeiting that costs the industry approximately $2B a year.
High drug prices and easily available label technology have spawned a burgeoning counterfeit drug trade. 5-10 percent of prescription medications on the market today are counterfeit or diverted product, according to the World Health Organization. Consumers and legislators are demanding action to clamp down on this growing problem. Florida and California recently enacted legislation requiring electronic pedigrees to track the origin of prescription drugs. In the southeast, Wal-Mart is requiring its suppliers to apply RFID tags to all SKUs, including prescription and over-the-counter medications that pass through its 12 distribution centers in the southeast. And all medications sold to the military must be electronically tagged at all locations to verify the authenticity of the product.
"Government and the pharmaceutical industry are working together to combat drug counterfeiting and the utilization of new electronic tracking technologies for e-pedigree compliance is becoming the standard," said Andre Pino, Chief Marketing Officer of Acsis, Inc. "Some of the world's foremost pharmaceutical companies have found our automated Serialized Track and Trace solution to be an ideal and cost effective way to help them meet this new industry requirement."
The Acsis Serialized Track and Trace Solution for Life Sciences is a Service Oriented Architecture-based platform that automates and streamlines the collection of e-pedigree data during manufacturing and packaging processes to lessen the incidence of drug counterfeiting. The Acsis solution enables automatic tagging and tracking of serialized products within operations, from receipt through manufacturing, inventory, picking, packaging and shipping—providing critical real-time visibility into item-level product movements, from the manufacturer to the distributor to the pharmacy and any third-party partners in between, helping stakeholders ensure the authenticity of each item produced and sold under their brand name.
Acsis ran live demonstrations of its Serialized Track and Trace Solution for Life Sciences at the National Association of Chain Drug Stores and Healthcare Distribution Management Association RFID Health Care Industry Adoption Summit at the Marriott Wardman Park Hotel in Washington, D.C.
About Acsis
Acsis, Inc. was founded in 1996 and is headquartered in Marlton, N.J. Acsis is a
global enterprise software and services provider that automates manufacturing
and supply chain processes enabling higher throughput at lower costs. With
implementations in 26 countries Acsis provides a single platform that connects
people, devices, and supply chains, enabling adaptive manufacturing and supply
chain operations. Acsis is an SAP Services Partner, SAP Technology Partner
and charter member of SAP's Enterprise Services Community. Acsis also
maintains partnerships with major service and hardware providers. Acsis is an
EPCglobal member and early adopter of RFID technologies. Acsis is a partner
company of Safeguard Scientifics, Inc. (NYSE: SFE). Additional information can
be found at www.ascsisinc.com.
About Safeguard
Safeguard Scientifics, Inc. (NYSE: SFE) builds value in high-growth, revenuestage
information technology and life sciences businesses. Safeguard provides
growth capital as well as a range of strategic, operational and management
resources to its partner companies. Safeguard participates in expansion
financings, corporate spin-outs, management buyouts, recapitalizations, industry
consolidations and early-stage financings. www.safeguard.com